CME Group Meets on the Top Line, Misses Where it Counts
CME Group (NAS: CME) reported earnings on Feb. 5. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), CME Group met expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue dropped and GAAP earnings per share contracted significantly.
Gross margins dropped, operating margins grew, net margins shrank.
CME Group tallied revenue of $660.9 million. The 14 analysts polled by S&P Capital IQ anticipated sales of $661.9 million on the same basis. GAAP reported sales were 10% lower than the prior-year quarter's $736.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.63. The 17 earnings estimates compiled by S&P Capital IQ predicted $0.64 per share. GAAP EPS of $0.50 for Q4 were 78% lower than the prior-year quarter's $2.25 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 97.1%, 20 basis points worse than the prior-year quarter. Operating margin was 56.8%, 380 basis points better than the prior-year quarter. Net margin was 25.2%, 7,610 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $720.2 million. On the bottom line, the average EPS estimate is $0.75.
Next year's average estimate for revenue is $3.01 billion. The average EPS estimate is $3.25.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 769 members out of 819 rating the stock outperform, and 50 members rating it underperform. Among 233 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 222 give CME Group a green thumbs-up, and 11 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on CME Group is outperform, with an average price target of $57.26.
Can your portfolio provide you with enough income to last through retirement? You'll need more than CME Group. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add CME Group to My Watchlist.
The article CME Group Meets on the Top Line, Misses Where it Counts originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool owns shares of CME Group. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.